Comparison of short-term toxicity between Nano-Se and selenite in mice

被引:271
作者
Zhang, ES [1 ]
Wang, HL
Yan, XX
Zhang, LD
机构
[1] Univ Sci & Technol China, Hefei 230052, Peoples R China
[2] Chinese Acad Sci, Inst Solid Phys, Hefei 230031, Peoples R China
[3] Anhui Med Univ, Hefei 230001, Peoples R China
关键词
toxicity; Nano-Se; selenite;
D O I
10.1016/j.lfs.2004.08.015
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We previously reported that, as compared with selenite, nano red elemental selenium (Nano-Se) had lower acute toxicity in mice and similar bioavailability in terms of up-regulating seleno-enzymes. The short-term toxicity of both selenite and Nano-Se in mice was further compared in this study. At an oral dose of 6 mg/kg bw per day administered for consecutive 12 days, selenite and Nano-Se completely and partially suppressed mice growth respectively. Abnormal liver function was more pronounced with selenite treatment than Nano-Se as indicated by the increase of both alanine aminotransferase and aspartate aminotransferase in serum. Selenite inhibited liver catalase and superoxide dismutase activities, whereas, Nano-Se did not affect these two antioxidant enzymes. Selenite increased the malondialdehyde content of liver, but Nano-Se decreased it. Both Se forms had similar effects on depletion of reduced glutathione and up-regulated glutathione peroxidase. Nano-Se was more potent than selenite in the induction of glutathione S-transferase. At oral doses of 2 or 4 mg/kg bw per day for consecutive 15 days, selenite was more active than Nano-Se in supressing growth, deleting reduced glutathione, and inhibiting superoxide dismutase activities. Taken together, these results indicate that over a short-term, a high-dose of selenite caused more pronounced oxidative stress, greater liver injury, and prominent retardation of growth as compared to Nano-Se. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:1099 / 1109
页数:11
相关论文
共 38 条
[1]  
ANIKINA LV, 1995, TOXICOL LETT, V78, P18
[2]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[3]   Selective modulation of the therapeutic efficacy of anticancer drugs by selenium containing compounds against human tumor xenografts [J].
Cao, SS ;
Durrani, A ;
Rustum, YM .
CLINICAL CANCER RESEARCH, 2004, 10 (07) :2561-2569
[4]  
Claiborne A., 1985, CRC HDB METHODS OXYG, P283
[5]   Bioavailability of selenium accumulated by selenite-reducing bacteria [J].
Combs, GF ;
Garbisu, C ;
Yee, BC ;
Yee, A ;
Carlson, DE ;
Smith, NR ;
Magyarosy, AC ;
Leighton, T ;
Buchanan, BB .
BIOLOGICAL TRACE ELEMENT RESEARCH, 1996, 52 (03) :209-225
[6]   Inorganic selenium retards progression of experimental hormone refractory prostate cancer [J].
Corcoran, NM ;
Najdovska, M ;
Costello, AJ .
JOURNAL OF UROLOGY, 2004, 171 (02) :907-910
[7]   TISSUE SULFHYDRYL GROUPS [J].
ELLMAN, GL .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1959, 82 (01) :70-77
[8]   Selenium (Se) from high-selenium broccoli is utilized differently than selenite, selenate and selenomethionine, but is more effective in inhibiting colon carcinogenesis [J].
Finley, JW ;
Davis, CD .
BIOFACTORS, 2001, 14 (1-4) :191-196
[9]  
Gao XY, 2002, ADV MATER, V14, P290, DOI 10.1002/1521-4095(20020219)14:4<290::AID-ADMA290>3.3.CO
[10]  
2-L